Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Jahnavi Nidumolu and Krystal Hu (Reuters) -Twitter’s cash flow remains negative because of a...
MOSCOW (Reuters) – President Vladimir Putin said Russia had a “sufficient stockpile” of cluster bombs...
In the world of finance, the adage that ‘money talks’ rings particularly true when...
Ex-Goldman Sachs Group Inc (NYSE:GS) hedge fund hotshot, Raoul Pal, is sounding the alarm...
(This July 15 story has been refiled to fix typographical errors in paragraphs 3 and...
In a recent discussion as part of the Amazon Advisor Call Series, Scott Devitt,...
By Yew Lun Tian BEIJING (Reuters) – A Chinese naval flotilla set off on Sunday...
By Stephen Nellis, Andrea Shalal and Karen Freifeld (Reuters) – The chief executives of Intel...
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...